REMICADE 100 mg/10mL
INFLIXIMAB · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Janssen Biotech, Inc.
No Recall History
Plain English
REMICADE is a injection, powder, lyophilized, for solution containing infliximab at 100 mg/10mL, taken intravenous. Manufactured by Janssen Biotech, Inc..
Key Facts
- Brand Name
- REMICADE
- Generic Name
- INFLIXIMAB
- NDC Code (Product)
57894-030- Manufacturer
- Janssen Biotech, Inc.
- Strength
- 100 mg/10mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA103772
- Drug Class
- Tumor Necrosis Factor Blocker [EPC]
- Marketing Start
- 08/24/1998
Recall History
No Recall HistoryFrequently Asked Questions
What is REMICADE used for?
REMICADE contains INFLIXIMAB. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is REMICADE a controlled substance?
REMICADE is not classified as a controlled substance by the DEA.
What is the generic name for REMICADE?
The generic name for REMICADE is INFLIXIMAB. There are 6 other brand versions of INFLIXIMAB.
What is the NDC code for REMICADE 100 mg/10mL?
The NDC (National Drug Code) for REMICADE 100 mg/10mL is 57894-030, listed by Janssen Biotech, Inc..